ARCEVA DS SYP NEW

ARCEVA DS SYP is an artemether and lumefantrine combination syrup formulation designed for the treatment of uncomplicated malaria. This fixed-dose combination works synergistically to target malaria parasites at multiple stages of their lifecycle, providing rapid symptom relief and effective parasite clearance. The syrup formulation ensures easy administration and better palatability, making it suitable for patients who have difficulty swallowing tablets. Artemether acts quickly to reduce parasitemia, while lumefantrine provides sustained antimalarial activity and helps prevent recrudescence. Ideal for both adults and children requiring effective malaria management.